| Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer A Abravan, C Faivre-Finn, J Kennedy, A McWilliam, M van Herk Journal of Thoracic Oncology 15 (10), 1624-1635, 2020 | 116 | 2020 |
| Novel methodology to investigate the effect of radiation dose to heart substructures on overall survival A McWilliam, J Khalifa, EV Osorio, K Banfill, A Abravan, C Faivre-Finn, ... International Journal of Radiation Oncology* Biology* Physics 108 (4), 1073-1081, 2020 | 78 | 2020 |
| Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival A McWilliam, A Abravan, K Banfill, C Faivre-Finn, M van Herk Journal of Thoracic Oncology 18 (5), 599-607, 2023 | 29 | 2023 |
| Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported? F Sun, K Franks, L Murray, J Lilley, B Wheller, K Banfill, A McWilliam, ... Lung Cancer 146, 1-5, 2020 | 21 | 2020 |
| Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy A McWilliam, C Dootson, L Graham, K Banfill, A Abravan, M Van Herk Physics and Imaging in Radiation Oncology 15, 46-51, 2020 | 20 | 2020 |
| Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy A Abravan, HA Eide, Å Helland, E Malinen Clinical and translational radiation oncology 22, 15-21, 2020 | 20 | 2020 |
| Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study A Abravan, A Salem, G Price, C Faivre-Finn, M van Herk Acta Oncologica 61 (2), 163-171, 2022 | 17 | 2022 |
| Skin toxicity profile of photon radiotherapy versus proton beam therapy in paediatric and young adult patients with sarcomas S Gaito, A Abravan, J Richardson, M Lowe, DJ Indelicato, N Burnet, ... Clinical Oncology 33 (8), 507-516, 2021 | 12 | 2021 |
| A predictive model for reactive tube feeding in head and neck cancer patients undergoing definitive (chemo) radiotherapy S Gaito, A France, P Foden, A Abravan, N Burnet, K Garcez, VR Kota, ... Clinical Oncology 33 (10), e433-e441, 2021 | 11 | 2021 |
| Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib A Abravan, HA Eide, IS Knudtsen, AM Løndalen, Å Helland, E Malinen Clinical and translational radiation oncology 4, 57-63, 2017 | 10 | 2017 |
| Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy A Abravan, G Price, K Banfill, T Marchant, M Craddock, J Wood, MC Aznar, ... Frontiers in Oncology 12, 934369, 2022 | 8 | 2022 |
| Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy HA Eide, IS Knudtsen, V Sandhu, AM Løndalen, AR Halvorsen, ... Advances in Radiation Oncology 3 (2), 130-138, 2018 | 7 | 2018 |
| Dysphagia at 1 year is associated with mean dose to the inferior section of the brain stem EV Osorio, A Abravan, A Green, M Van Herk, LW Lee, D Ganderton, ... International Journal of Radiation Oncology* Biology* Physics 117 (4), 903-913, 2023 | 6 | 2023 |
| Predictive value of vascular calcification identified in 4D planning CT of lung cancer patients treated with stereotactic body radiation therapy A Abravan, M Van Herk, F Brewster, C Faivre-Finn, A McWilliam, ... Physica Medica 78, 173-178, 2020 | 6 | 2020 |
| A new method to assess pulmonary changes using 18F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy A Abravan, IS Knudtsen, HA Eide, AM Løndalen, Å Helland, P van Luijk, ... Acta Oncologica 56 (11), 1597-1603, 2017 | 6 | 2017 |
| Qualitative study on diversity, equity, and inclusion within radiation oncology in Europe A Abravan, D Correia, A Gasnier, S Shakhverdian, T van der Stok, ... International Journal of Radiation Oncology* Biology* Physics 116 (2), 246-256, 2023 | 5 | 2023 |
| Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer K Banfill, A Abravan, M van Herk, F Sun, K Franks, A McWilliam, ... Frontiers in Oncology 12, 1007577, 2022 | 5 | 2022 |
| Mapping bone marrow response in the vertebral column by positron emission tomography following radiotherapy and erlotinib therapy of lung cancer A Abravan, HA Eide, AM Løndalen, Å Helland, E Malinen Molecular Imaging and Biology 21, 391-398, 2019 | 5 | 2019 |
| OC-0441 Risk of cardiac death increases with dose to cardiac sub structure avoidance region in lung cancer A Abravan, C Faivre-Finn, K Banfill, A McWilliam, M van Herk Radiotherapy and Oncology 170, S385-S386, 2022 | 2 | 2022 |
| Demystifying cardiac dose in RTOG-0617 A McWilliam, A Abravan, K Banfill, C Faivre-Finn, M van Herk International Journal of Radiation Oncology, Biology, Physics 111 (3), S125, 2021 | 2 | 2021 |
